Zhao and coworkers demonstrated that the FTX lncRNA promotes the progression of colorectal cancer (CRC) by targeting the miR-192-5p/EIF5A2 axis (Zhao et al., 2020b). The gene discussed is FTX; the disease is colorectal carcinoma.